Previous Close | 25.77 |
1-Year Change | 111.92% |
6-Months Change | 42.77% |
3-Months Change | 6.89% |
Moving Avg (50d) | 22.284 |
Moving Avg (200d) | 20.599 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.04B |
Beta (3-Years) | 0.85 |
Revenue Growth (ttm) | 12.63% |
Net Profit Margin (ttm) | 1.75% |
Return On Assets (ttm) | 1.5% |
EPS (ttm) | 0.48 |
PE Ratio (ttm) | 53.69 |
Dividend Yield | 1.86% |
Asset Description: | Phibro Animal Health Corporation |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-02-12 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
26.285 | 27.059 | 27.574 | 28.347 | 29.636 | 30.924 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |